Hijdra A, van Gijn J, Nagelkerke N J, Vermeulen M, van Crevel H
Department of Neurology, University Hospital Dijkzigt, Rotterdam, The Netherlands.
Stroke. 1988 Oct;19(10):1250-6. doi: 10.1161/01.str.19.10.1250.
Using logistic regression, we analyzed the predictive value of a number of entry variables with respect to the outcome variables delayed cerebral ischemia, rebleeding, and poor outcome (death or severe disability) in patients with aneurysmal subarachnoid hemorrhage. The entry variables were clinical condition on admission (grades on the Glasgow Coma Scale, Hunt and Hess system), the amount of subarachnoid and intraventricular blood and the presence of hydrocephalus on the admission computed tomogram, and antifibrinolytic treatment with tranexamic acid. We used data from a prospectively studied population of 176 patients admitted within 72 hours after subarachnoid hemorrhage. The risk of delayed cerebral ischemia was best predicted by the amount of subarachnoid blood, intraventricular blood, and antifibrinolytic treatment irrespective of clinical condition and hydrocephalus. The site of delayed cerebral ischemia was not related to the location of the subarachnoid hemorrhage. Antifibrinolytic treatment was the only entry variable (negatively) predicting the risk of rebleeding. Death or severe disability after 3 months was best predicted by the amount of subarachnoid blood and the initial clinical condition reflected by the grade on the Glasgow Coma Scale.
我们使用逻辑回归分析了一系列输入变量对动脉瘤性蛛网膜下腔出血患者迟发性脑缺血、再出血和不良预后(死亡或严重残疾)等输出变量的预测价值。输入变量包括入院时的临床状况(格拉斯哥昏迷量表评分、Hunt和Hess分级系统)、蛛网膜下腔和脑室内出血量、入院计算机断层扫描显示的脑积水情况以及氨甲环酸抗纤溶治疗。我们使用了前瞻性研究的176例蛛网膜下腔出血后72小时内入院患者的数据。不论临床状况和脑积水情况如何,蛛网膜下腔出血量、脑室内出血量和抗纤溶治疗对迟发性脑缺血风险的预测效果最佳。迟发性脑缺血的部位与蛛网膜下腔出血的位置无关。抗纤溶治疗是唯一(呈负相关)预测再出血风险的输入变量。蛛网膜下腔出血量和格拉斯哥昏迷量表评分所反映的初始临床状况对3个月后的死亡或严重残疾的预测效果最佳。